Literature DB >> 18031390

Influence of Helicobacter pylori genotype on triple eradication therapy.

Jian Jun Zhao1, Jiang Bin Wang, Lei Yang, Yan Li.   

Abstract

BACKGROUND: The efficiency of Helicobacter pylori eradication varies geographically, as do many parameters that might affect therapeutic efficiency. The aims of this study were to investigate the relationship between different genotypes of H. pylori and bacterium-related histopathological lesions in patients with duodenal ulcer and to determine the effect of genotype on triple eradication therapy.
METHODS: Helicobacter pylori infections were analyzed in 78 duodenal ulcer patients. The cytotoxin-associated gene (cagA) and vacuolating cytotoxin gene (vacA) subtype status of cultured strains were studied by PCR. Histopathological findings were graded using a described grading system. The patients were treated with triple-therapy regimens consisting of a proton pump inhibitor and two antibiotics twice daily for 7 days. Endoscopy was repeated at 4 weeks post-therapy to monitor ulcer healing and H. pylori eradication.
RESULTS: The bacteria were genotyped from 66 patients, 57 of whom had H. pylori eradicated. The absence of cagA was associated with unsuccessful treatment. No difference was found with regard to vacA subtype between the successful and unsuccessful eradication groups. On histopathological examination, high H. pylori colonization density and intestinal metaplasia were associated with low eradication rate, while a high grade of neutrophil infiltration was associated with a significantly higher eradication rate.
CONCLUSIONS: The data confirm the importance of cagA positivity as a predictor of successful eradication. When high H. pylori colonization density and intestinal metaplasia are present, therapy appears to be less effective. Therefore, these histopathological features may be involved in an unsuccessful therapeutic outcome.

Entities:  

Mesh:

Year:  2007        PMID: 18031390     DOI: 10.1111/j.1440-1746.2007.04836.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Association of helicobacter pylori dupA with the failure of primary eradication.

Authors:  Seiji Shiota; Lam Tung Nguyen; Kazunari Murakami; Akiko Kuroda; Kazuhiro Mizukami; Tadayoshi Okimoto; Masaaki Kodama; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

2.  Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.

Authors:  Mohsen Karbalaei; Amin Talebi Bezmin Abadi; Masoud Keikha
Journal:  BMC Infect Dis       Date:  2022-06-25       Impact factor: 3.667

Review 3.  Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

4.  The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis.

Authors:  Dan Wang; Qiuping Li; Yuehua Gong; Yuan Yuan
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

5.  Effect of treatment failure on the CagA EPIYA motif in Helicobacter pylori strains from Colombian subjects.

Authors:  Javier Andres Bustamante-Rengifo; Andres Jenuer Matta; Alvaro Jairo Pazos; Luis Eduardo Bravo
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.